Predicting life expectancy remains in the realm of science fiction, but it may soon be possible. Are we prepared for such information? And who else would benefit from this knowledge?
Academic rigor, journalistic flair
Articles on Biomedical ethics
Displaying all articles
Yes, there are pros and cons of this new reproductive technology. But there are many other issues about maternal and child health we need to tackle first.
We worry about AI developing consciousness, but brain organoids may be more likely to do so.
The pope, presidents and parents can voice their opinion on right-to-die cases, but they shouldn't get to decide.
CRISPR babies may be just the beginning. China has a different take than the West on ethics and how to get ahead in business and other endeavors.
A team in the U.S. is said to have safely and effectively altered human embryos. The news is a reminder that citizens must be consulted on developments potentially affecting the future of the species.
The news may have come as a surprise, but it probably shouldn't have. A bioethics expert walks through how big a deal this announcement is – and what we should be considering now.
The high-profile Charlie Gard case could change the way end-of-life decisions play out around the world.
BCI devices that read minds and act on intentions can change lives for the better. But they could also be put to nefarious use in the not-too-distant future. Now's the time to think about risks.
What rights should a chimera with human-like cognitive abilities but without the ability to speak have?
Maybe you think neuroscience has a peaceable history of benign efforts to improve lives and enhance human capacities. But its origins and development tell a different story – with ethical implications.
A UK court has allowed a 14-year-old girl's body to be frozen until doctors find a cure for the cancer that killed her. Is this latest example of cryogenics hope, hype or hell?
It is ethical for doctors to accept a treatment option parents want – providing it is good enough – rather than insisting on what they believe is the best possible treatment for the child.
Regulations, funding and public opinion around genetically enhancing future generations vary from country to country. Here's why China may be poised to be the pioneer.
The rise of personalised medicine, which is mainly based on genetic testing, needs adequate regulation so privacy rights aren't breached. That's only one of several issues that must be considered.
Top contributors
-
Associate Professor in Law, Deakin University
-
Professor of Law, University of Tasmania
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Research Fellow in Ethics, University of Melbourne
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Associate Professor, Faculty of Law, University of Technology Sydney
-
Research Assistant Professor in Biomedical Ethics, National University of Singapore
-
Wellcome Trust Research Fellow in Philosophy, University of Oxford
-
Assistant Professor of International Relations, Rutgers University Newark
-
Adjunct Assistant Professor of Neurology at Oregon Health and Sciences University and Affiliate Assistant Professor of Philosophy, University of Washington
-
Ph.D. Student in Electrical Engineering, University of Washington
-
Associate Dean (Computing and Security), Edith Cowan University
-
Professor of Cognitive Neuroscience, Bangor University
-
Research Professor, Philosophy, Dalhousie University
-
Law Dean; Professor of Law; and Professor of Bioethics & Public Health, Case Western Reserve University
